For example, the expression level of HLA-C affects the risk of graft versus host disease (GVHD) after hematopoietic stem cell transplantation (HSCT), but also the clinical outcome of human immunodeficiency virus infection and Crohn’s disease [26, 27]. This evidence concerns the gene HLA-C and graft versus host disease.